insights_auto
Why is PTX up 3.33%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.062
arrow_upward
+3.33%(+0.0020) 1D
Nov 11, 3:12:18 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
66.19M
Avg. vol.
585.90K
Volume
575.21K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
66.19M
Avg. vol.
585.90K
Volume
575.21K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Edge Higher After Red-Hot Inflation Data And Nvidia Losses: CRWV, TTWO, NLST, NBIS In Focus
Benzinga
·
48 minutes ago
Dow Falls Over 150 Points Following Inflation Report: Greed Index Remains In ‘Fear’ Zone
Big News Network.com
·
8 hours ago
Dow Jones slides 158 points Tuesday, Nasdaq sheds 187
Traders Union
·
4 hours ago
Correlations rose sharply between ex-AI basket and S&P 500 last week, Jurrien Timmer notes
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteptxtherapeutics.com